Table 2.
Demographic data among the studied groups.
| Control (N= 30) | Rheumatoid Patients (N= 79) | p-value | Sig. | ||||
|---|---|---|---|---|---|---|---|
| Low Disease Activity(N= 24) | Moderate Disease Activity (N= 24) | High Disease Activity(N= 31) | |||||
| Age (years) | 42±6.7 | 48.2±9.75 | 44.25±10.38 | 46.77±9.76 | > 0.05 | NS | |
| Duration (years) | 4.85±5.09 | 4.7±4.38 | 2.67±2.6 | > 0.05 | NS | ||
| DAS28 | 2.8±0.12 | 4.5±0.5 a | 16.5±6.6 a, b | <0.001a, b | HS | ||
| Sex | Male | 15 (50%) | 5 (6.3%) | <0.001* | HS | ||
| Female | 15 (50%) | 74 (93.7%) * | |||||
Data are expressed as mean±SD. P-value< 0.05 is considered statistically significant. HS: highly significant.
a
Significant difference versus the low disease activity group.
b
significant difference versus the moderate disease activity group.
*
Significant difference between males and females in the rheumatoid arthritis group.